-
I was reading another blog, and realized Comedy Central now has their own site with videos and ran across this classic from the Today Show. With all the recent discussions on how big Pharma spends money and recent marketing techniques, here it is in all it's glory. BD http://www.thedailyshow...
-
Interesting correlation on how the move business and Pharma share similar business plans when it comes to producing a blockbuster drug. R and D, yup, got high costs with both, unpredictable, yup, nobody knows until the release, budgets and flops, well it could be a toss up over which industry can...
-
More big fish, small fish in the Pharma business, this time a 3rd Japanese firm buying a US Company. Are there going to be many left here in the US, Pfizer we love you. BD Shionogi, is buying Sciele Pharma, a small, publicly traded drug maker based in Atlanta. The all-cash deal is...
-
With all the focus on cancer of late, which is of course very important, it's nice to see some other research and good clinical results for other chronic conditions, such as Gout. I have watch my mother, who is 84 years old, and who is also a diabetic who has gout, for years, trying to balance...
-
This article brings up a good point, when a patient has no other choices and the potential of a new drug could offer some relief, what is the verdict at this point? The FDA has turned it's way of thinking around now to being much more conservative on the drugs that are approved. Do the drug companies...
-
Well back to the drawing board to gather up some additional data. We live in a world of data today, overloaded data for that matter, and decisions just are not as simple as they used to be. With all the additional side effects coming to light the FDA appears to be taking the same stance as...
-
The most amazing part of this article is the cost compared to OxyContin, that was an eye opener for me, not being acquainted with pain killing medications. Xanax and Valium do not mix here either and we all remember the Anna Nicole Smith death, which probably accounted for bring methadone to the...
-
This brings up an interesting question, what do you go for relief or bankruptcy? Although now it is not real wide spread, but as the Biomed business continues to grow with new break throughs, how will this process continue? Is this more justification for biosimilars, the Biomed side of generic...
-
The patent is stated not to expire until 2010 and this will put a 30 hold at the FDA to grant approval. This one should prove interesting to follow and see where the infringement occurs. BD LONDON -(Dow Jones)- Sanofi-Aventis SA (SNY) has launched a legal action against Canadian generic drugmaker...
-
Hopefully more will come out on this story as to why and how. These are franchise locations, just like the local fast food businesses we visit, thus they are run locally under the terms and agreements of the franchise holder. If they were expired then it would be up to the local management...